Ahmedabad-based Cliantha Research acquires Karmic Lifesciences

The long list of funding and M&As in 2014 just got lengthier with the recent announcement from the lifesciences sector. Ahmedabad-based global lifesciences company offering clinical, bioanalytical, dermatology, biometrics, diagnostics and personal healthcare services, Cliantha Research has confirmed the acquisition of Karmic Lifesciences. Headquartered in Mumbai , Karmic Lifesciences is an ICH-GCP compliant contract research organization.

Karmic Lifesciences was one of the five featured companies in our Startup Watchlist published two weeks ago.

Subscribe to our mailing list- Startup Watchlist now.

Karmic recently has successfully launched medico-marketing services for the pharmaceutical industry. Karmic Lifesciences founded in 2005 by Nidhi Saxena, a first generation woman entrepreneur and boast of a successful track record of executing 150+ Clinical Trials and 75+ Clinical Data Management & Bio-Statistics Projects (Phase I to IV) in various therapeutic areas including Oncology, Cardiovascular, Diabetes, Neurology, Auto-Immune Diseases, Ophthalmology, and Medical Devices.

Nidhi says,

Cliantha brings in strong Clinical, Bio-Analytical and Diagnostics capabilities that lend huge synergy to our existing clinical business apart from the strategic flexibility and financial stability of a well-established partner. Together we hope to provide an end-to-end services portfolio to our global clients.

Karmic Lifesciences has developed kTrials™, a web-enabled eClinical suite with integrated clinical trial management, clinical data management, clinical data warehousing and operational analytics functionalities. It is designed especially to support Karmic’s end-to-end Global Clinical Operations, Data management and project management requirements. The system supports end-to-end operational activities right from project set-up, planning, budgeting, execution, performance analytics and reporting for all clinical trials conducted by Karmic apart from storing all clinical and operational enterprise data as well as electronic trial master files in a single repository.

In 2011, Cliantha acquired Hill Top Research, a leading global CRO in USA & Canada providing services in Phase I, Dermatology Rx and Personal Healthcare. Vijay Patel, Executive Director of Cliantha Research comments,

Karmic gives us an opportunity to expand in the clinical data management, pharmaceutical analytics and medical marketing business. Nidhi and her team have developed a robust clinical data management eSuite: kTrials™. We shall immediately be able to execute and port all our trials onto kTrials™ eClinical Suite. Moving forward our goal is to provide kTrials™ as SaaS application to the pharmaceutical industry.